C21 Investments Stock Short Ratio
CXXIF Stock | USD 0.24 0.02 9.09% |
C21 Investments fundamentals help investors to digest information that contributes to C21 Investments' financial success or failures. It also enables traders to predict the movement of C21 OTC Stock. The fundamental analysis module provides a way to measure C21 Investments' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to C21 Investments otc stock.
C21 |
C21 Investments OTC Stock Short Ratio Analysis
C21 Investments' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition |
Based on the latest financial disclosure, C21 Investments has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
C21 Fundamentals
Return On Equity | 0.1 | |||
Return On Asset | 0.0622 | |||
Profit Margin | 0.05 % | |||
Operating Margin | 0.21 % | |||
Current Valuation | 42.26 M | |||
Shares Outstanding | 120.05 M | |||
Shares Owned By Insiders | 16.48 % | |||
Shares Owned By Institutions | 7.51 % | |||
Price To Earning | 4.10 X | |||
Price To Book | 0.80 X | |||
Price To Sales | 0.84 X | |||
Revenue | 32.98 M | |||
Gross Profit | 18.81 M | |||
EBITDA | 20.26 M | |||
Net Income | 10.92 M | |||
Cash And Equivalents | 2.34 M | |||
Cash Per Share | 0.02 X | |||
Total Debt | 2.03 M | |||
Debt To Equity | 0.42 % | |||
Current Ratio | 0.68 X | |||
Book Value Per Share | 0.31 X | |||
Cash Flow From Operations | 6.84 M | |||
Earnings Per Share | 0.03 X | |||
Beta | 2.96 | |||
Market Capitalization | 35.52 M | |||
Total Asset | 61.85 M | |||
Z Score | 10.2 | |||
Net Asset | 61.85 M |
About C21 Investments Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze C21 Investments's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of C21 Investments using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of C21 Investments based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in C21 OTC Stock
C21 Investments financial ratios help investors to determine whether C21 OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in C21 with respect to the benefits of owning C21 Investments security.